# Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial

*PRI Rank #12 · Topics and Trends in Most Cited Bacteriophages and microbial interactions Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/bacteriophages-and-microbial-interactions/2026/rank-12*

| Field | Value |
| --- | --- |
| Rank | #12 |
| 18m citations | 67 |
| Journal | The Lancet Infectious Diseases |
| Year | 2024 |
| DOI | 10.1016/s1473-3099(24)00424-9 |
| Corresponding authors | Paul Kim |
| Institution | Locus Biosciences, United States |

**Ranking page:** [Topics and Trends in Most Cited Bacteriophages and microbial interactions Papers, Class of 2026](https://pri.pepkio.com/top-papers/bacteriophages-and-microbial-interactions/2026)

**Paper link:** [10.1016/s1473-3099(24)00424-9](https://doi.org/10.1016/s1473-3099(24)00424-9)

## Topics

LBP-EC01 · CRISPR-Cas3 · Phage cocktails · uncomplicated urinary tract infections · Escherichia coli · ELIMINATE trial · phase 2 trial · pharmacokinetics · pharmacodynamics · Engineered phages · Phage therapy · Antimicrobial resistance · bacteriophage safety · UTI treatment

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Bacteriophages and microbial interactions Papers, Class of 2026. https://pri.pepkio.com/top-papers/bacteriophages-and-microbial-interactions/2026. Accessed 2026-07-17.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```